However, there was no significant difference in the serum levels of the two commonly used tumor biomarkers—carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 153—between breast cancer patients with or without distant metastasis (Fig. 5b, c). Here, CEACAM5 is linked to breast cancer.